Form 8-K - Current report:
SEC Accession No. 0001193125-23-115402
Filing Date
2023-04-25
Accepted
2023-04-25 16:31:07
Documents
50
Period of Report
2023-04-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d83948d8k.htm   iXBRL 8-K 28494
2 EX-99.1 d83948dex991.htm EX-99.1 53578
6 GRAPHIC g83948ex99_1s10g1.jpg GRAPHIC 254490
7 GRAPHIC g83948ex99_1s11g1.jpg GRAPHIC 239086
8 GRAPHIC g83948ex99_1s12g1.jpg GRAPHIC 272688
9 GRAPHIC g83948ex99_1s13g1.jpg GRAPHIC 316024
10 GRAPHIC g83948ex99_1s14g1.jpg GRAPHIC 122823
11 GRAPHIC g83948ex99_1s15g1.jpg GRAPHIC 413805
12 GRAPHIC g83948ex99_1s16g1.jpg GRAPHIC 327048
13 GRAPHIC g83948ex99_1s17g1.jpg GRAPHIC 278404
14 GRAPHIC g83948ex99_1s18g1.jpg GRAPHIC 283325
15 GRAPHIC g83948ex99_1s19g1.jpg GRAPHIC 413000
16 GRAPHIC g83948ex99_1s1g1.jpg GRAPHIC 273522
17 GRAPHIC g83948ex99_1s20g1.jpg GRAPHIC 283649
18 GRAPHIC g83948ex99_1s21g1.jpg GRAPHIC 92392
19 GRAPHIC g83948ex99_1s22g1.jpg GRAPHIC 394337
20 GRAPHIC g83948ex99_1s23g1.jpg GRAPHIC 124303
21 GRAPHIC g83948ex99_1s24g1.jpg GRAPHIC 295739
22 GRAPHIC g83948ex99_1s25g1.jpg GRAPHIC 244792
23 GRAPHIC g83948ex99_1s26g1.jpg GRAPHIC 300987
24 GRAPHIC g83948ex99_1s27g1.jpg GRAPHIC 280758
25 GRAPHIC g83948ex99_1s28g1.jpg GRAPHIC 349715
26 GRAPHIC g83948ex99_1s29g1.jpg GRAPHIC 227354
27 GRAPHIC g83948ex99_1s2g1.jpg GRAPHIC 689371
28 GRAPHIC g83948ex99_1s30g1.jpg GRAPHIC 221153
29 GRAPHIC g83948ex99_1s31g1.jpg GRAPHIC 268888
30 GRAPHIC g83948ex99_1s32g1.jpg GRAPHIC 296896
31 GRAPHIC g83948ex99_1s33g1.jpg GRAPHIC 327569
32 GRAPHIC g83948ex99_1s34g1.jpg GRAPHIC 363202
33 GRAPHIC g83948ex99_1s35g1.jpg GRAPHIC 258718
34 GRAPHIC g83948ex99_1s36g1.jpg GRAPHIC 336814
35 GRAPHIC g83948ex99_1s37g1.jpg GRAPHIC 364028
36 GRAPHIC g83948ex99_1s3g1.jpg GRAPHIC 394212
37 GRAPHIC g83948ex99_1s4g1.jpg GRAPHIC 253549
38 GRAPHIC g83948ex99_1s5g1.jpg GRAPHIC 243594
39 GRAPHIC g83948ex99_1s6g1.jpg GRAPHIC 250204
40 GRAPHIC g83948ex99_1s7g1.jpg GRAPHIC 411498
41 GRAPHIC g83948ex99_1s8g1.jpg GRAPHIC 384781
42 GRAPHIC g83948ex99_1s9g1.jpg GRAPHIC 409646
  Complete submission text file 0001193125-23-115402.txt   15739817

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agle-20230425.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20230425_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20230425_pre.xml EX-101.PRE 11258
44 EXTRACTED XBRL INSTANCE DOCUMENT d83948d8k_htm.xml XML 3358
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 23845293
SIC: 2834 Pharmaceutical Preparations